McGrath Pam, Phillips Emma
International Program of Psycho-Social Health Research, Central Queensland University, Kenmore Old, Australia.
Issues Compr Pediatr Nurs. 2008 Jan-Mar;31(1):37-54. doi: 10.1080/01460860701877209.
This article presents the findings of a five-year longitudinal study exploring the treatment experience for families coping with leukemia and lymphoma to address the dearth of psycho-social research documenting the experience of childhood lymphoma patients. The participants noted that the predominant differences for lymphoma families, as compared with other childhood hematological conditions, center around the issues of, firstly, the intensity of treatment. While the treatment protocol is comparatively shorter, the parents perceive it to be more arduous due to the intense and continuous nature of treatment. Important issues noted in this regard were the negative impact of the toxicity of the chemotherapeutic drugs, the stress associated with the invasiveness of accessing the child's veins for blood samples and to inject medications and the experience of undergoing lumbar punctures. Secondly, the relatively rare occurrence of pediatric lymphoma was reported to result in feelings of isolation from other families with children with a hematological malignancy and the unavailability of information and support services focusing specifically on childhood lymphoma. Thirdly, the relatively high curative success rate of lymphomas can have the effect that the parents feel that their angst is somewhat trivialized by other parents at the hospital. Recommendations include the importance of the availability of the full range of supportive care services, attention to the difficult emotional states the child patients experience, clinical strategies that lessen the trauma of treatment, and the use of positive role models by way of contact with or information of children who have successfully completed treatment.
本文介绍了一项为期五年的纵向研究结果,该研究探索了白血病和淋巴瘤患儿家庭的治疗经历,以填补心理社会研究中关于记录儿童淋巴瘤患者经历的空白。参与者指出,与其他儿童血液疾病相比,淋巴瘤家庭的主要差异首先集中在治疗强度问题上。虽然治疗方案相对较短,但由于治疗的强度和持续性,父母认为治疗更加艰巨。在这方面指出的重要问题包括化疗药物毒性的负面影响、因采集孩子血样和注射药物时侵入性操作带来的压力以及腰椎穿刺的经历。其次,据报告,儿童淋巴瘤相对罕见,这导致患儿家庭与其他患有血液恶性肿瘤孩子的家庭产生隔离感,且缺乏专门针对儿童淋巴瘤的信息和支持服务。第三,淋巴瘤相对较高的治愈率可能会使父母觉得他们的焦虑在医院被其他父母有些轻视。建议包括提供全方位支持性护理服务的重要性、关注儿童患者经历的困难情绪状态、减轻治疗创伤的临床策略,以及通过与成功完成治疗的儿童接触或提供相关信息来树立积极榜样。